Evolus Inc (EOLS) Stock Analysis

Evolus Inc (EOLS) is a publicly traded company in the HEALTHCARE sector. It trades at $6.17, carries a market capitalization of $429.37M. This page summarizes the public market data, fundamentals, and frequently asked questions for EOLS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Evolus Inc currently has a Bullish sentiment score of 0.24.

About Evolus Inc

Evolus, Inc. is a dynamic aesthetic medical company based in Newport Beach, California, renowned for its innovative beauty solutions tailored for healthcare providers and their patients. The company’s flagship product, Jeuveau, is a neurotoxin uniquely developed for the cosmetic market, demonstrating Evolus's commitment to quality and efficacy in enhancing aesthetic results. As a pivotal entity within the expanding aesthetic industry, Evolus is focused on broadening its portfolio and penetrat...

GNG Research Analysis

GNG Research scores Evolus Inc (EOLS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for EOLS.

Frequently Asked Questions

Does EOLS pay dividends?

Evolus Inc (EOLS) does not currently pay a regular dividend.

What is EOLS's market cap?

Evolus Inc (EOLS) has a market capitalization of $429.37M with a current stock price of $6.17.